TOFACITINIB CITRATE | A220137 | SOMERSET THERAPEUTICS LLC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
| D. Del. | 2025-05-16 | Terminated 2025-10-01 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
No patent or exclusivity listings for this strength.
Somerset Therapeutics added ANDA 220137 for tofacitinib citrate to FDA's regulatory database.
New: New record
Somerset Therapeutics added tofacitinib citrate (NDA 220137, Supplement 001) to the FDA's approved product database.
New: New record